Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Genuit meets full-year profit forecasts as markets stabilise

(Sharecast News) - Building products group Genuit saw a return to underlying growth in the second half as market conditions stabilised, and said it expects to offset impending wage bill increases through operational improvements this year. The company, which provides water, climate and ventilation solutions for the built environment, had warned changes in the Autumn Budget - notably minimum wage increases and higher National Insurance contributions - would add £5m to the cost base this year.

"The group is targeting, through productivity and balanced cost and price management, to offset the previously disclosed £5m in-year impact of the Autumn Budget on operating profit margin for the full year," Genuit said.

Despite this, the group expects to increase underlying operating margins to above 20% in the medium term, up from 16.4% in 2024.

Revenues totalled £561.3m last year, down 4.3% on 2023, after what chief executive Joe Vorih called a "challenging year for the sector, with ongoing market softness leading to reduced volumes across most segments".

However, after a 10.6% drop in like-for-like revenues in the first half, LFL revenues increased by 0.5% in the second half.

Underlying operating profits fell 2% to £92.2m, as a weaker top line was partially offset by a 40-basis point improvement in the underlying operating margin. This was in line with the company-compiled consensus range of £92m-94m.

The board proposed a total dividend for the year of 12.5p, up from 12.4p paid out in 2023.

"We saw some signs of market stabilisation in the second half of 2024 and market volumes in the early part of this year have been in line with management expectations," Vorih said.

"Our growth prospects remain strong, given the need for investment in UK infrastructure and housing. As a result, we are well-placed to take advantage of a market recovery when it comes, with strong operational gearing and a robust balance sheet enabling us to continue investing in Genuit's long-term success."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.